EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo

Tessy A H Hick, Corinne Geertsema, Wilson Nguyen, Cameron R Bishop, Linda van Oosten, Sandra R Abbo, Troy Dumenil, Frank J M van Kuppeveld, Martijn A Langereis, Daniel J Rawle, Bing Tang, Kexin Yan und 3 weitere

Molecular Therapy · 2024-08 · 32 (8) · 2519-2534

DOI: 10.1016/j.ymthe.2024.06.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2024-08. Verfasst von Tessy A H Hick und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology, Wageningen University and Research, Wageningen, the Netherlands. Hauptthemen laut MEDLINE: mRNA Vaccines, Alphavirus, Recombination, Genetic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Technology Foundation STW, National Health and Medical Research Council, Erasmus Medisch Centrum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Self-amplifying mRNA (SAM) vaccines can be rapidly deployed in the event of disease outbreaks. A legitimate safety concern is the potential for recombination between alphavirus-based SAM vaccines and circulating viruses. This theoretical risk needs to be assessed in the regulatory process for SAM vaccine approval. Herein, we undertake extensive in vitro and in vivo assessments to explore recombination between SAM vaccine and a wide selection of alphaviruses and a coronavirus. SAM vaccines were found to effectively limit alphavirus co-infection through superinfection exclusion, although some co-replication was still possible. Using sensitive cell-based assays, replication-competent alphavirus chimeras were generated in vitro as a result of rare, but reproducible, RNA recombination events. The chimeras displayed no increased fitness in cell culture. Viable alphavirus chimeras were not detected in vivo in C57BL/6J, Rag1-/- and Ifnar-/- mice, in which high levels of SAM vaccine and alphavirus co-replicated in the same tissue. Furthermore, recombination between a SAM-spike vaccine and a swine coronavirus was not observed. In conclusion we state that although the ability of SAM vaccines to recombine with alphaviruses might be viewed as an environmental safety concern, several key factors substantially mitigate against in vivo emergence of chimeric viruses from SAM vaccine recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

mRNA VaccinesAlphavirusRecombination, GeneticAnimalsMiceMice, Inbred C57BLHumansReceptor, Interferon alpha-betaVirus ReplicationHomeodomain ProteinsVaccines, SyntheticMice, KnockoutSARS-CoV-2Viral Vaccines

Stichwörter der Autor:innen

RNA recombinationSAM vaccinealphaviruschimeracoronavirusrepliconsafety concernself-amplifying mRNAsuperinfection exclusion

Substanzen

mRNA VaccinesReceptor, Interferon alpha-betaRAG-1 proteinHomeodomain ProteinsIfnar1 protein, mouseVaccines, SyntheticViral Vaccines

Autor:innen und Institutionen

  • Laboratory of Virology, Wageningen University and Research, Wageningen, the Netherlands.
  • Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia.
  • Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, the Netherlands.
  • Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia; Global Virus Network Centre of Excellence, Australian Infectious Diseases Research Centre, Brisbane, QLD 4072 and 402…
  • Laboratory of Virology, Wageningen University and Research, Wageningen, the Netherlands. Electronic address: gorben.pijlman@wur.nl.

Förderung

  • Technology Foundation STW
  • National Health and Medical Research Council
  • Erasmus Medisch Centrum
  • University of Queensland
  • Ministry of Infrastructure and Water Management
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Hick, T. A. H., Geertsema, C., Nguyen, W., Bishop, C. R., van Oosten, L., Abbo, S. R., Dumenil, T., van Kuppeveld, F. J. M., Langereis, M. A., Rawle, D. J., Tang, B., Yan, K., van Oers, M. M., Suhrbier, A., & Pijlman, G. P. (2024). Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo. Molecular Therapy, 32(8), 2519-2534. https://doi.org/10.1016/j.ymthe.2024.06.019

Vancouver

Hick TAH, Geertsema C, Nguyen W, Bishop CR, van Oosten L, Abbo SR, et al. Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo. Molecular Therapy. 2024;32(8):2519-2534. doi:10.1016/j.ymthe.2024.06.019

BibTeX
@article{Hick2024,
  author = {Hick, Tessy A H and Geertsema, Corinne and Nguyen, Wilson and Bishop, Cameron R and van Oosten, Linda and Abbo, Sandra R and Dumenil, Troy and van Kuppeveld, Frank J M and Langereis, Martijn A and Rawle, Daniel J and Tang, Bing and Yan, Kexin and van Oers, Monique M and Suhrbier, Andreas and Pijlman, Gorben P},
  title = {Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo},
  journal = {Molecular Therapy},
  year = {2024},
  volume = {32},
  number = {8},
  pages = {2519--2534},
  doi = {10.1016/j.ymthe.2024.06.019}
}
Kostenlos starten →